Home › NCT06570603

Targeting Components of Distress Tolerance

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Fluent in English
* Uses Android or iPhone smartphone
* Depression Anxiety and Stress Scale (DASS-21) scores of 42 and higher
* Distress Intolerance Index (DII) scores of 3 or higher

Exclusion Criteria:

* Work or School that does not allow consistent access to phone (or is unsafe)
* No internet access for completing follow-up surveys

About the study

The goal of this clinical trial is to learn which aspects of distress intolerance (i.e., difficulties withstanding upsetting emotional states) are the most important for improving effective emotion regulation and associated mental health symptoms.

The main questions it aims to answer are:

How are willingness to feel upset and self-efficacy for withstanding distress associated with different emotion regulation strategies used in daily life?

Does targeting willingness to feel upset and/or self-efficacy for withstanding distress help people use more effective emotion regulation strategies in daily life when they feel upset?

Are improvements in emotion regulation strategies in daily life associated with fewer symptoms of mental health problems over time?

Participants will:

Answer questions about their moods, willingness to feel upset, self-efficacy for withstanding distress and emotion regulation strategies for three weeks using a cell phone app

Undergo a willingness, self-efficacy, combined or psychoeducational control intervention in the lab

Be prompted to use the intervention skill via the cell phone app during the second week, after the intervention

Complete weekly reports of mental health symptoms

What is being tested

• Self-Efficacy (behavioral)
• Willingness (behavioral)
• Psychoeducation (behavioral)

Sponsor: University of Arkansas, Fayetteville · Participants: 240 · Started: Oct 3, 2024

Contact the study team

• Jennifer C Veilleux, PhD · Phone: 479-575-5329

Official record on ClinicalTrials.gov — NCT06570603

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.